mAb Process Intensification And Scale-Up
-
Upstream To Downstream: A Comprehensive Approach To AAV Production
12/7/2023
How can you face the challenges of AAV production, scale up your AAV manufacturing effectively, and enhance the recovery and purity in your downstream processing.
-
Planning for Success: Supply Resiliency Strategies for Bench to Production
10/18/2023
Build scalable material sourcing strategies for R&D and early phases through to commercialization and learn how to accelerate the development process and ensure the scalability of your biologics.
-
The Technology Debate: Single-Use vs. Stainless Steel
10/4/2023
In this discussion you will explore the multi-point case for adopting single-use technologies throughout the workflow via an economic, operational, and environmental sustainability lens.
-
The Role Of Peptones In Boosting Quality And Yield
11/4/2024
Peptones can significantly boost CHO cell bioprocessing. We analyze their impact on diverse CHO cell lines using real-world data to assess their effects on titer, protein quality, and cell growth.
-
Scalable Production Of Lentivirus For Research To Commercial Manufacturing
10/30/2024
Join our webinar on scaling the CTS LV-MAX System in bioreactors, covering transfection scalability, Thermo S.U.B. advantages, and DynaSpin’s efficient gene therapy integration.
-
The Way Forward: Supply Chain Solutions
10/24/2024
Learn how to build a resilient supply chain to navigate today's complex environment. Expert speakers share insights on optimization, innovation, and strategic planning to meet evolving market conditions.
-
mAb Up- And Downstream Process Intensification Strategies
12/12/2024
Discover how to reduce monoclonal antibody (mAb) manufacturing time and costs through process intensification. Learn about continuous perfusion, ultrahigh cell density banks, and more.